Frost & Sullivan Recognizes XiFin as a Revenue Cycle Management Company of the Year

We are proud to be named Frost & Sullivan’s 2017 North American Revenue Cycle Management Company of the Year in the diagnostic laboratory segment. This award is based on a 10-step process to assess companies for best practices, visionary innovation and performance, and customer impact. Frost & Sullivan recognizes XiFin based on our innovative software platform, connectivity tools, and our revenue cycle management (RCM) system’s ability to address the most significant challenges facing clinical laboratories today.

Frost & Sullivan principal analyst, Divyaa Ravishankar said, “XiFin’s RCM solution, XiFin RPM, is superior and unrivaled in the diagnostic services market because it enables laboratories and other diagnostic service providers to operate efficiently, collaboratively and in a more sustainable manner in healthcare’s uncertain and ever-changing regulatory environment. In addition, customers that have invested in XiFin RPM highly praise its solutions for demonstrating a solid increase in cash collections, laboratory productivity and efficiency.”

The report summarizes that XiFin has, “established an environment where diagnostic providers can extract the maximum advantage from available information and establish connectivity with other stakeholders to maximize reimbursement, thereby helping labs manage their finances more efficiently and effectively.”

Specifically, Frost & Sullivan cite six key differentiators that enable our RPM solution to excel in laboratory diagnostics:

1. Automated optimized workflow
2. Strong technological foundation
3. Financial underpinnings
4. Connectivity
5. Business Intelligence
6. Expertise and Managed Services

Our Chief Executive Officer, Lâle White added, “This award validates our continued commitment to providing the most comprehensive RCM solutions available for diagnostic service providers. We look forward to continuing to advance connected health solutions and optimize the business of healthcare.”